Skip to content

Safety and tolerability of a skin sensor for glucose and lactate

Safety and tolerability study of a minimally invasive microneedle sensor for monitoring glucose and lactate

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN70604753
Enrollment
15
Registered
2026-06-19
Start date
2026-09-21
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers Other

Interventions

This study involves 15 healthy volunteers divided into three groups of five. The research is designed to test a new wearable skin sensor (a biosensor) that uses tiny "microneedles" to measure two heal

Sponsors

University of Liverpool
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Male or Female, 18-45 years of age 2. Be in good health 3. Able and willing to comply with all study requirements 4. Negative pregnancy test (female participants)

Exclusion criteria

Exclusion criteria: The participant may not enter the study if ANY of the following apply: 1. Previously diagnosed chronic medical condition 2. Female participant who is pregnant, lactating or planning pregnancy during the course of the study 3. Predisposition to bleeding 4. Predisposition to skin infection or inflammation including a history of atopic dermatitis 5. Participants who have participated in another research study involving an investigational product in the past 12 weeks or plan to participate during the course of the study 6. Under investigation for malignancy 7. Allergy to any component of sensor

Design outcomes

Primary

MeasureTime frame
Safety measured using absence of serious adverse events and absence of needle breakage at end of follow-up;Tolerability measured using Visual Analogue Scale pain score less than 3 out of 10 at point of sensor removal

Secondary

MeasureTime frame
Accuracy measured using a comparison of sensor-derived glucose and lactate measurements with time-matched venous reference measurements obtained using the Siemens RAPIDPoint 500e Blood Gas System at 1 hour and at each interim measurement until device removal

Countries

England, United Kingdom

Contacts

Public ContactGreta;Benedict Wood;Michael

;

greta.wood@liverpool.ac.uk;Benedict.Michael@liverpool.ac.uk+44 0151 706 4860;+44 0151 706 4860

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 25, 2026